How to take Calocurb: three schedules, one 500 mg dose
How to take Calocurb: the brand's schedule, the CLINICAL label and the C4 trial protocol side by side, converted to mg of Amarasate a day.
How to take Calocurb: the brand's schedule, the CLINICAL label and the C4 trial protocol side by side, converted to mg of Amarasate a day.
Calocurb side effects, counted: the 24-week C4 trial's withdrawals and dose cuts for diarrhea and nausea, set against the brand pages' 'rare' and 'mild'.
FDA published a company announcement of a nationwide voluntary recall of Lipofit Extreme Fat Burner 2.0 over undeclared fluoxetine and 2,4-dinitrophenol. Two undeclared substances, two very different kinds of failure.
The FDA notified consumers about Esbelta Intense Loss and Esbelta Chupapanza Flat Belly on 18 August. This is not substitution and it is not underdosing — it is undeclared pharmaceutical ingredients, which no amount of label arithmetic would have caught.
Reported on 12 August: three more online weight-loss products added to the FDA's yellow oleander alert, which now runs to 25. The failure here is not a dose problem — it is that the plant in the capsule was not the plant on the label.
A May ruling held that a weight-loss supplement's own name would be read as a health claim the advertiser could not show was authorised — and that an injection-pen comparison table put it in the territory of prescription medicines.
Two words that can mean a rigorous trial or almost nothing at all. Here is what the phrase does not commit a brand to.
The supplement category did not compete with prescription weight-loss drugs. It borrowed their vocabulary instead — and that borrowing is the thing worth watching on a label.